Escin Ia suppresses the metastasis of triple-negative breast cancer by inhibiting epithelial-mesenchymal transition via down-regulating LOXL2 expression
about
The positive clinical therapeutically effects of Escin on advanced thyroid cancer.β-escin selectively targets the glioblastoma-initiating cell population and reduces cell viability.Escin induces caspase-dependent apoptosis and autophagy through the ROS/p38 MAPK signalling pathway in human osteosarcoma cells in vitro and in vivo.
P2860
Escin Ia suppresses the metastasis of triple-negative breast cancer by inhibiting epithelial-mesenchymal transition via down-regulating LOXL2 expression
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Escin Ia suppresses the metast ...... wn-regulating LOXL2 expression
@en
Escin Ia suppresses the metast ...... n-regulating LOXL2 expression.
@nl
type
label
Escin Ia suppresses the metast ...... wn-regulating LOXL2 expression
@en
Escin Ia suppresses the metast ...... n-regulating LOXL2 expression.
@nl
prefLabel
Escin Ia suppresses the metast ...... wn-regulating LOXL2 expression
@en
Escin Ia suppresses the metast ...... n-regulating LOXL2 expression.
@nl
P2093
P2860
P356
P1433
P1476
Escin Ia suppresses the metast ...... wn-regulating LOXL2 expression
@en
P2093
P2860
P304
23684-23699
P356
10.18632/ONCOTARGET.8152
P407
P577
2016-03-17T00:00:00Z